RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $221.4M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $118.0K in total
- 4
- 13F holdersQ2 2026, −11 vs. previous quarter
- 151
- 13F valueReported value at the end of Q2 2026
- $199.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $134.5M
- −3.9% year over year
- Net income, FY2025
- -$38.9M
- No comparable prior period
- Free cash flow, FY2025
- -$19.3M
- No comparable prior period
- Revenue, Q3 FY2026
- $24.6M
- −19.0% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $38.9M (29.0% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 3.63M
- Shares sold short
- Change
- −485.2K
- −11.8% vs. previous
- Days to cover
- 6.07
- At average daily volume
Superinvestors holding RXST, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding RXST at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by RxSight, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)9:35 PM ET | Sep 2 | Same day | Kurtz Ronald M MDChief Medical Officer | SSale | −5.10K | $6.96 | −$35.5K | −6.6%71.8K after | |
| Sep 2, 2026 (view filing)9:35 PM ET | Sep 2 | Same day | Wilterding MarkChief Financial Officer | SSale | −7.76K | $6.96 | −$54.0K | −23.7%25.0K after | |
| Sep 2, 2026 (view filing)9:34 PM ET | Sep 2 | Same day | Goldshleger IlyaChief Operating Officer | SSale | −2.04K | $6.96 | −$14.2K | −2.4%81.5K after | |
| Sep 2, 2026 (view filing)9:33 PM ET | Sep 2 | Same day | Weinberg EricSee remarks | SSale | −2.04K | $6.96 | −$14.2K | −1.0%200.3K after | |
| Mar 13, 2025 (view filing) | Mar 12 | 1 day | Fountain TamaraDirector | SSale | −7.00K | $25.71 | −$180.0K | −22.0%24.8K after | 10b5-1 |
| Jan 27, 2025 (view filing) | Jan 22 | 5 daysLate | Maniar ShwetaDirector | SSale | −3.52K | $30.87 | −$108.6K | −32.3%7.38K after | 10b5-1 |
| Jan 17, 2025 (view filing) | Jan 15-16 | 2 days | Corley Jesse AndersonDirector | PPurchase | +3.21K | $31.16 | +$100.0K | New position3.21K after | 2 lots |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Goldshleger IlyaSee remarks | SSale | −3.10K | $46.08 | −$143.1K | −6.8%42.2K after | 10b5-1 |
| Nov 26, 2024 (view filing) | Nov 26 | Same day | Maniar ShwetaDirector | SSale | −3.78K | $45.88 | −$173.5K | −25.8%10.9K after | 10b5-1 |
| Nov 26, 2024 (view filing) | Nov 22-26 | 4 days | Goldshleger IlyaSee remarks | SSale | −6.20K | $45.44 | −$281.7K | −12.8%42.2K after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 151 holdersThe largest institutional positions in RxSight, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,790,408 | $27.9M | 0.00% | +2,603,316+81.7% | Added |
| Millennium Management LLC | 3,030,287 | $14.6M | 0.01% | +970,828+47.1% | Added |
| No Street GP LP | 2,055,000 | $9.91M | 0.60% | +55,000+2.8% | Added |
| Nomura Holdings Inc | 2,000,060 | $9.64M | 0.04% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 1,985,215 | $9.57M | 0.01% | +25,483+1.3% | Added |
| Vanguard Capital Management LLC | 1,675,582 | $8.08M | 0.00% | −17,353−1.0% | Reduced |
| AQR Capital Management LLC | 1,533,826 | $7.39M | 0.00% | +897,697+141.1% | Added |
| Acadian Asset Management LLC | 1,501,180 | $7.22M | 0.01% | +482,053+47.3% | Added |
| Federated Hermes, Inc. | 1,201,195 | $5.79M | 0.01% | +120,483+11.1% | Added |
| Two Sigma Investments, LP | 1,147,048 | $5.53M | 0.00% | −153,212−11.8% | Reduced |
Holders of 5% or more of RXST
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of RxSight, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 13G/A | 8.40%3.49M shares | +1.20 ppfrom 7.20% | Jul 17, 20262 filings | Oct 27, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.90%2.85M shares | +1.10 ppfrom 5.80% | Oct 22, 20244 filings | Oct 27, 2026 | SEC |
| Point72 Asset Management, L.P. | 13G | 6.00%2.49M shares | New | Aug 19, 20261 filing | Aug 19, 2026 | SEC |
| Millennium Management LLC | 13G | 5.20%2.19M shares | +0.10 ppfrom 5.10% | Jul 15, 20255 filings | Nov 10, 2026 | SEC |
| Artisan Partners Limited Partnership | 13G/A | 5.00%2.06M shares | −0.20 ppfrom 5.20% | Feb 12, 20246 filings | May 13, 2026 | SEC |